NCT03058367View on ClinicalTrials.gov

Benefit and Tolerability of IQP-AE-103 in Weight Loss

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

November 28, 2017

Study Completion Date

November 28, 2017

Conditions
OverweightObesity
Interventions
DIETARY_SUPPLEMENT

IQP-AE-103 (330mg)

High dose capsules

DIETARY_SUPPLEMENT

IQP-AE-103 (165mg)

Low dose capsules

DIETARY_SUPPLEMENT

Placebo

Placebo identical to verum capsules

Trial Locations (1)

Unknown

Analyze & Realize, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY